5-(3,4-Dimethylphenyl)-3-methyl-2-sulfanyl-3H,4H-thieno[2,3-d]pyrimidin-4-one

Catalog No. :
ACVZPR265
CAS No. :
786728-91-4
Molecular Formula :
C15H14N2OS2
Molecular Weight :
302.42

IUPAC Name:5-(3,4-dimethylphenyl)-2-mercapto-3-methylthieno[2,3-d]pyrimidin-4(3H)-one

5-(3,4-Dimethylphenyl)-3-methyl-2-sulfanyl-3H,4H-thieno[2,3-d]pyrimidin-4-one structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
50mg95%$70.00Login to see priceInquiryInquiry
100mg95%$101.00Login to see priceInquiryInquiry
250mg95%$132.00Login to see priceInquiryInquiry
1g95%$339.00Login to see priceInquiryInquiry
5g95%$950.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name5-(3,4-Dimethylphenyl)-3-methyl-2-sulfanyl-3H,4H-thieno[2,3-d]pyrimidin-4-one
IUPAC Name5-(3,4-dimethylphenyl)-2-mercapto-3-methylthieno[2,3-d]pyrimidin-4(3H)-one
MDL No.MFCD06355955
Molecular FormulaC15H14N2OS2
Molecular Weight302.42
SMILESO=C1C(C(C2=CC=C(C)C(C)=C2)=CS3)=C3N=C(S)N1C
InChI KeyUDKXJQPVAJAGSW-UHFFFAOYSA-N
SynonymThieno[2,3-d]pyrimidin-4(1H)-one, 5-(3,4-dimethylphenyl)-2,3-dihydro-3-methyl-2-thioxo-;5-(3,4-Dimethylphenyl)-3-methyl-2-sulfanyl-3H,4H-thieno[2,3-d]pyrimidin-4-one
CAS No.786728-91-4

Synthetic Route by SureRoute

1. ACVZPR265 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACWULS130 route compound structure diagram
    ACWULS13055499-43-9 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACVZPR265 route product structure diagram
    ACVZPR265786728-91-4
Inquiry

2. ACVZPR265 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACBSVJ248 route compound structure diagram
    ACBSVJ248401797-00-0 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACVZPR265 route product structure diagram
    ACVZPR265786728-91-4
Inquiry

Comments (0)